Mkts

Mereo BioPharma Group plc

NASDAQ: MREO
$0.30+0.00 (-0.96%)
As of Nov 5, 9:53 AM ET

Key statistics

Day range
0.290.31
52-week range
0.202.37
Today
Open0.31
Previous close0.30
Volume—
Valuation
Market cap46.45M
P/E ratio—
EPS (TTM)-0.03
Income & risk
Dividend / yield—
Beta0.21
Avg volume3.12M
Discussion

MREO News

Stories mentioning MREO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.00500.000.000.000.00
Cost of Goods Sold
Gross Profit0.000.00
Operating Expenses
Research & Development4,7474,1934,2705,3733,9308,8203,1704,946
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(8,766)(8,391)(10,015)(10,499)(11,202)(15,277)(9,373)(12,814)
Interest Income327.00421.00504.00589.00659.00882.00983.00559.00
Interest Expense20.0023.0028.0024.00180.00376.00353.00331.00
Other Expense0.000.000.00
Pretax Income(6,719)(7,351)(7,024)(14,616)(12,887)(7,046)(15,001)(12,255)
Tax Provision0.000.000.000.000.000.000.000.00
Net Income (Loss)(6,719)(7,351)(7,024)(14,616)(12,887)(7,046)(15,001)(12,255)
Earnings Per Share (Basic)(0.01)(0.01)(0.01)(0.02)(0.02)(0.01)(0.02)(0.02)
Earnings Per Share (Diluted)(0.01)(0.01)(0.01)(0.02)(0.02)(0.01)(0.02)(0.02)
Weighted Average Shares Outstanding (Basic)801,806797,120799,947799,435784,279739,624770,147770,147
Weighted Average Shares Outstanding (Diluted)801,806797,120799,947799,435784,279739,624770,147770,147

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About MREO

Mereo BioPharma Group plc (NASDAQ: MREO) is a stock listed on the Nasdaq Stock Market under the ticker symbol MREO. It last traded at $0.3000 (Nov 5, 2026, 9:53 AM ET), down 1.0% on the day. That gives Mereo BioPharma a market capitalisation of $46.4M.

Over the past 52 weeks MREO has traded between $0.2000 and $2.37.

For the quarter ended Mar 31, 2026 it reported a net loss of $6.7M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$6.7M—
Dec 31, 2025—-$7.4M—
Sep 30, 2025$0-$7.0M—
Jun 30, 2025$500.0K-$14.6M-2923.2%

From Mereo BioPharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…